title: Management of diabetic foot infections in an era of increasing microbial resistance.
abstract: Diabetic foot infections cause substantial morbidity, incur significant costs, and may lead to amputation. Resistant organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant gram-negative organisms, are becoming more prevalent. Optimal management of diabetic foot infections is multimodal, and includes not only antimicrobial therapy but also biomechanical support and offloading, local wound care, glycemic control, assessment and treatment of underlying vascular disease, and surgical therapy when warranted. Antimicrobial therapy should be targeted at the likely etiologic agents and should take into consideration the depth and severity of infection. With expansion of the reservoir of resistant organisms, obtaining reliable deep cultures can help focus antimicrobial therapy against the dominant pathogens. Newer agents against resistant gram-positive and gram-negative organisms show promise in the treatment of diabetic foot infections.
authors.affiliation: Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, GRJ-504, Boston, MA 02114, USA. sbnelson@partners.org
authors.forename: Sandra Bliss
authors.initials: SB
authors.lastname: Nelson
references.citation: Diabet Med. 1999 Sep;16(9):767-71
references.pmid: 10510954
references.citation: Clin Infect Dis. 2008 Dec 15;47(12):1537-45
references.pmid: 18990064
references.citation: J Clin Microbiol. 2007 Sep;45(9):2819-28
references.pmid: 17609322
references.citation: Antimicrob Agents Chemother. 2005 Oct;49(10):4368-71
references.pmid: 16189124
references.citation: J Antimicrob Chemother. 2007 Oct;60(4):819-23
references.pmid: 17673476
references.citation: Diabetologia. 2007 Jan;50(1):18-25
references.pmid: 17093942
references.citation: J Antimicrob Chemother. 2004 Oct;54(4):836-9
references.pmid: 15375105
references.citation: Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S145-61
references.pmid: 18442163
references.citation: Diabetes Metab. 2008 Sep;34(4 Pt 1):363-9
references.pmid: 18632297
references.citation: Diabet Med. 2004 Jul;21(7):705-9
references.pmid: 15209762
references.citation: Diabetes Res Clin Pract. 2007 Jan;75(1):47-50
references.pmid: 16963148
references.citation: Antimicrob Agents Chemother. 2006 Aug;50(8):2875-9
references.pmid: 16870792
references.citation: Clin Infect Dis. 2004 Aug 1;39 Suppl 2:S104-14
references.pmid: 15306988
references.citation: Dtsch Med Wochenschr. 2001 Nov 30;126(48):1353-6
references.pmid: 11727160
references.citation: Diabetes Care. 2006 Jun;29(6):1288-93
references.pmid: 16732010
references.citation: N Engl J Med. 2003 Apr 3;348(14):1342-7
references.pmid: 12672861
references.citation: Clin Infect Dis. 2008 Aug 15;47(4):519-27
references.pmid: 18611152
references.citation: Diabet Med. 2004 Jul;21(7):710-5
references.pmid: 15209763
references.citation: Diabetes Care. 2008 Apr;31(4):637-42
references.pmid: 18184898
references.citation: PLoS One. 2008 Oct 03;3(10):e3326
references.pmid: 18833331
references.citation: Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):370-2
references.pmid: 18723960
references.citation: J Chemother. 2006 Dec;18(6):648-51
references.pmid: 17267344
references.citation: J Infect. 2007 May;54(5):439-45
references.pmid: 17018235
references.citation: J Chemother. 2005 Oct;17(5):527-35
references.pmid: 16323442
references.citation: Clin Infect Dis. 2004 Oct 1;39(7):885-910
references.pmid: 15472838
references.citation: Eur J Intern Med. 2005 Dec;16(8):567-70
references.pmid: 16314237
references.citation: Diabet Med. 2003 Feb;20(2):159-61
references.pmid: 12581269
references.citation: JAMA. 2008 Feb 20;299(7):806-13
references.pmid: 18285592
references.citation: Clin Infect Dis. 2006 Jan 1;42(1):57-62
references.pmid: 16323092
references.citation: Diabetes Res Clin Pract. 2008 Jun;80(3):344-51
references.pmid: 18291550
references.citation: Clin Infect Dis. 2004 Aug 1;39 Suppl 2:S115-22
references.pmid: 15306989
references.citation: Int J Low Extrem Wounds. 2006 Sep;5(3):213-6
references.pmid: 16928678
references.citation: Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S66-71
references.pmid: 18395871
references.citation: Clin Infect Dis. 2004 Jun 15;38(12):1673-81
references.pmid: 15227611
references.citation: Diabet Med. 2001 Oct;18(10):822-7
references.pmid: 11678973
references.citation: Clin Infect Dis. 2004 Jan 1;38(1):17-24
references.pmid: 14679443
references.citation: JAMA. 2005 Jan 12;293(2):217-28
references.pmid: 15644549
references.citation: J Antimicrob Chemother. 2005 Feb;55(2):240-5
references.pmid: 15659542
references.citation: Clin Microbiol Infect. 2006 Feb;12(2):186-9
references.pmid: 16441460
references.citation: Diabetes Care. 2007 Feb;30(2):270-4
references.pmid: 17259493
references.citation: Antimicrob Agents Chemother. 2006 Nov;50(11):3959-62
references.pmid: 16982780
references.citation: Clin Microbiol Infect. 2007 Apr;13(4):351-3
references.pmid: 17359317
references.citation: Lancet. 2005 Nov 12;366(9498):1695-703
references.pmid: 16291062
references.citation: Clin Infect Dis. 2009 Apr 1;48(7):888-93
references.pmid: 19228109
references.citation: Diabet Med. 2004 Sep;21 Suppl 4:16-9
references.pmid: 15315521